Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Navidea Biopharmaceuticals Inc    

No quotes available
-- USD   --.--%
08/09 NAVIDEA BIOPHAR : reports 2Q loss
05/16 NAVIDEA BIOPHAR : NAVB) Files An 8-K Other Events
05/10 NAVIDEA BIOPHAR : posts 1Q profit
 SummaryNewsCalendarCompanyFinancials 
Company
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic.It is developing multiple precision-targeted products based on their manocept platform to help identify the sites and pathways of undetected disease and... 
Sector
Biotechnology & Medical Research
Calendar

- No events available -

More about the company
Latest news on NAVIDEA BIOPHARMACEUTICALS
08/09 NAVIDEA BIOPHARMACEUTICALS : Management's Discussion and Analysis of Financial C..
08/09 NAVIDEA BIOPHARMACEUTICALS, INC. : Results of Operations and Financial Condition..
08/09 NAVIDEA BIOPHARMACEUTICALS : reports 2Q loss
06/30 NAVIDEA BIOPHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security H..
06/29 NAVIDEA BIOPHARMACEUTICALS, INC. : Other Events (form 8-K)
05/16 NAVIDEA BIOPHARMACEUTICALS, INC. (NY : NAVB) Files An 8-K Other Events
05/16 NAVIDEA BIOPHARMACEUTICALS, INC. : Other Events (form 8-K)
05/10 NAVIDEA BIOPHARMACEUTICALS : Management's Discussion and Analysis of Financial C..
05/10 NAVIDEA BIOPHARMACEUTICALS : posts 1Q profit
05/09 NAVIDEA BIOPHARMACEUTICALS, INC. : Results of Operations and Financial Condition..
More news
Sector news : Biotechnology & Medical Research - NEC
08/17 FDA expands use of AstraZeneca/Merck ovarian cancer drug
08/15 Three CEOs resign from Trump council over Charlottesville
08/14DJHot Stocks to Watch in the U.S. and Canada
08/11DJGILEAD SCIENCES : England's NHS Turns to Clinical Trial to Make Cheaper HIV Drug..
08/11DJGILEAD SCIENCES : England's NHS Turns to Clinical Trial to Make Cheaper HIV Drug..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
08/09 Navidea Biopharm reports Q2 results
07/05 DAILY INSIDER RATINGS ROUND UP 7/3/1 : Mcc, cnbka, opk, cara, kfs, mmac
07/03 Navidea shareholders reject reverse split; shares -5.9%
06/29 Navidea settles litigation with FTI, agrees to pay $435K
06/20 Navidea inks commercialization deal in India for Tc 99m tilmanocept; shares u..
Income Statement Evolution
Managers
NameTitle
Mike M. Goldberg President, Chief Executive Officer & Director
Eric K. Rowinsky Chairman
Jed Andrew Latkin CFO, COO, Secretary & Treasurer
Frederick O. Cope Chief Scientific Officer & Senior Vice President
Mark I. Greene Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
NAVIDEA BIOPHARMACEUTICALS INC66
INCYTE CORPORATION20.86%24 929
QUINTILES IMS HOLDINGS INC20.38%19 823
LONZA GROUP40.29%17 682
CELLTRION, INC.--.--%11 804
ALKERMES PLC-8.38%7 821